LIPANTHYL

This brand name is authorized in Austria, Estonia, Finland, France, Hong Kong, Lithuania, Poland, Romania, Singapore, Tunisia, Turkey, South Africa

Active ingredients

The drug LIPANTHYL contains one active pharmaceutical ingredient (API):

1 Fenofibrate UNII U202363UOS - FENOFIBRATE

Fenofibrate is a fibric acid derivative whose lipid modifying effects reported in humans are mediated via activation of Peroxisome Proliferator Activated Receptor type α (PPARα). Through activation of PPARα, fenofibrate increases lipolysis and elimination of atherogenic triglyceride rich particles from plasma by activating lipoprotein lipase and reducing production of Apoprotein C-III. Read about Fenofibrate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LIPANTHYL Penta Film-coated tablet	Health Sciences Authority (SG)	MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C10AB05	Fenofibrate	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AB Fibrates
Discover more medicines within C10AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1026593
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 143196
Country: FR	Base de données publique des médicaments	Identifier(s): 62016239, 64563132, 65569444, 69612398
Country: HK	Department of Health Drug Office	Identifier(s): 44451, 50649, 57155
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003078
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100038040, 100094759, 100104699, 100140749, 100158376, 100274059, 100382116, 100433960, 100451372, 100463035
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68978001, W68978002, W68980001
Country: SG	Health Sciences Authority	Identifier(s): 11612P, 13615P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5540024, 5873121, 9043532
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699817030038, 8699820150259, 8699820150266, 8699820150358
Country: ZA	Health Products Regulatory Authority	Identifier(s): 30/7.5/0494, 41/7.5/0556